Let’s start a discussion here about Svenska Aerogel (AERO.ST) from the Stockholm Stock Exchange, as there didn’t seem to be one yet.
In short, the company has developed aerogel for mass production, which was previously considered a difficult process. The company is located in Gävle, Sweden. Their proprietary product is the aerogel-based Quartzene, which is used to add or improve the properties of end products. Below are a few highlights of these:
Svenska Aerogel winner in innovation competition - Quartzene, insulation with nanotechnology
The company has gone through a few share issues and is now finalizing the latest one. The funds from the issue will be used for marketing and sales, product development with customers, production development, and strengthening the cash position. The prospectus for the issue probably best illustrates the company’s current state and future plans; I recommend checking it out if you’re thinking of adding this to your portfolio.
The coming year is a moment of truth for the company, and they need to start generating sales. Personally, I was expecting this already in 2020, but COVID-19 certainly impacted sales, as the company’s sales organization isn’t huge yet and it must have been difficult to sell from Sweden to elsewhere.
The first production line was completed about a year ago. During the construction phase, they managed to make further improvements to the line, which, among other things, reduced water usage by 75% and raw material consumption by 30%. This line was the first phase of the Master Pilot Plant 2019 (MPP 2019) facility, where a total of four production lines are planned, with a combined capacity of 900 tons of Quartzene per year. That means 225 tons with the current single line.
The prospectus for the latest share issue also mentions that negotiations are underway with customers for significantly larger production volumes. The possibility of placing production lines directly at customer facilities, as part of their production chain, is also mentioned in the prospectus.
Information on the exact price of Quartzene has previously been scarce, but at the end of November, Svenska Aerogel announced they had hit a sales record and two previous customers placed follow-up orders. The quantities are still small, with a total of 2.5 tons sold in November, which is about 13% of what current capacity could handle monthly. However, the most important observation here was the total value of the orders, which was 680,000 SEK (€66,330), meaning ~€26,500 per ton or €26.5 per kilo.
Unfortunately, it wasn’t mentioned over what timeframe those orders of over a ton were renewed—whether they order more goods monthly or a few times a year. I would assume these are not yet monthly orders. However, this will likely become clearer in the future if/when sales start to pick up.
In terms of figures, however, at that price of €26,500/ton and the current annual production of 225 tons, the company has the potential to sell €5,962,500 worth of goods. The company’s current market capitalization is 60,623,000 SEK, or roughly €5.9 million. Of course, this will change again with the share issue as new shares enter the market, but the order of magnitude remains in the millions of euros.
Because of this, I believe the upside is massive if the sales team delivers. The negotiations mentioned in the prospectus for significantly larger production capacity would suggest that sales exceeding 225 tons per year could be relevant in 2021, if the current 225-ton production isn’t enough to satisfy the needs of said customers? How much they will exceed 225 tons is just guesswork at this stage and impossible even to speculate on. However, sales could potentially exceed the current market cap several times over.
So far, orders have mainly come in smaller quantities from Rayoung Chemtech, Novcoat, and Ekomarine, while larger players like Worlée Chemie GmbH (1, 2) and Barozzi Vernici have been involved in product development and negotiations. There are others too if you go through the press releases, but those are some examples.
There are plenty of risks here, as the company subsists on share issues and other financing, and has yet to generate a proper profit. Quartzene-based products have performed well in tests, so I believe the product is good. The biggest question mark for me regarding sales is whether the product is priced in a way that makes it worth using. In any case, Quartzene seems to be generating interest and some demand in the form of orders, but time will tell how sales fare. Personally, I will hold over 150,000 shares after Q3 2021 if the subscription rights/warrants from the issue can be fully exercised.
Someone more skilled in Swedish and numbers can correct me if I have (likely) misinterpreted things at some point or looked at it through overly blue-and-yellow tinted glasses.


